AIDS research prize for Warwick academic

August 04, 2015

A researcher at the University of Warwick has received international recognition for his contribution to AIDS research.

Dr Olalekan Uthman, assistant professor in research synthesis at the University's Warwick Medical School, has received the award for co-authoring the most cited article in the prestigious journal AIDS.

Titled Adherence to antiretroviral therapy during and after pregnancy in low-income, middle-income, and high-income countries: a systematic review and meta-analysis, the paper has been cited 94 times and was the most cited in its category in 2014.

Dr Uthman said: "The topic examined had not been covered before which is why I think it was so successful."

The international study examined patterns of antiretroviral medication taking in pregnant women with HIV. It identified that four months after delivery women took between 50-70% less medication. It also discovered that women from less wealthy countries were more likely to continue taking their medication than their counterparts in wealthier countries. The large scale study covered 16 countries including the Brazil, Kenya, South Africa, Thailand, the UK and the USA. More than 20 thousand women were monitored between 1986 and 2011.

The analysis has since been used by the World Health Organisation in developing its guidelines for monitoring the medication taking of pregnant women with HIV.

As well as an interest in long-term long therapies Dr Uthman's research interests include noncommunicable diseases (especially cardiovascular epidemiology) and interaction with infectious diseases (especially HIV/AIDS). He is the recipient of the FAS Marie Curie International Postdoc Fellowship to pursue research on the social and contextual determinants of HIV/AIDS, with a special emphasis on cardiovascular risk factors among HIV infected individuals.
Notes to Editors

The other authors of the papers are:

Jean B. Nachega (Centre for Infectious Diseases, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa); Jean Anderson (Department of Gynecology and Obstetrics, Johns Hopkins Hospital, Baltimore, MD, USA); Karl Peltzer (University of the Free State, Bloemfontein, South Africa); Sarah Wampold (Departments of International Health, Johns Hopkins Bloomberg School of Public Health, Baltimore); Mark Cotton (Department of Pediatrics, Faculty of Health Sciences, Stellenbosch University, Cape Town, South Africa); Edward J. Mills (Faculty of Health Sciences, University of Ottawa, Ottawa, Ontario, Canada); Yuh-Shan Ho (Trend Research Center, Asia University, Taichung, Taiwan); Jeffrey S. A. Stringer (Centre for Infectious Disease Research, Lusaka, Zambia and University of Alabama at Birmingham, USA); James McIntyre, MBChB, MCROG (School of Public Health & Family Medicine, University of Cape Town); Lynne Mofenson (Pediatric, Adolescent and Maternal AIDS Branch, Eunice Kennedy Shriver National Institute of Child Health and Human Development, National Institutes of Health, Bethesda, MD, USA)


University of Warwick

Related HIV Articles from Brightsurf:

BEAT-HIV Delaney collaboratory issues recommendations measuring persistent HIV reservoirs
Spearheaded by Wistar scientists, top worldwide HIV researchers from the BEAT-HIV Martin Delaney Collaboratory to Cure HIV-1 Infection by Combination Immunotherapy (BEAT-HIV Collaboratory) compiled the first comprehensive set of recommendations on how to best measure the size of persistent HIV reservoirs during cure-directed clinical studies.

The Lancet HIV: Study suggests a second patient has been cured of HIV
A study of the second HIV patient to undergo successful stem cell transplantation from donors with a HIV-resistant gene, finds that there was no active viral infection in the patient's blood 30 months after they stopped anti-retroviral therapy, according to a case report published in The Lancet HIV journal and presented at CROI (Conference on Retroviruses and Opportunistic Infections).

Children with HIV score below HIV-negative peers in cognitive, motor function tests
Children who acquired HIV in utero or during birth or breastfeeding did not perform as well as their peers who do not have HIV on tests measuring cognitive ability, motor function and attention, according to a report published online today in Clinical Infectious Diseases.

Efforts to end the HIV epidemic must not ignore people already living with HIV
Efforts to prevent new HIV transmissions in the US must be accompanied by addressing HIV-associated comorbidities to improve the health of people already living with HIV, NIH experts assert in the third of a series of JAMA commentaries.

The Lancet HIV: Severe anti-LGBT legislations associated with lower testing and awareness of HIV in African countries
This first systematic review to investigate HIV testing, treatment and viral suppression in men who have sex with men in Africa finds that among the most recent studies (conducted after 2011) only half of men have been tested for HIV in the past 12 months.

The Lancet HIV: Tenfold increase in number of adolescents on HIV treatment in South Africa since 2010, but many still untreated
A new study of more than 700,000 one to 19-year olds being treated for HIV infection suggests a ten-fold increase in the number of adolescents aged 15 to 19 receiving HIV treatment in South Africa, according to results published in The Lancet HIV journal.

Starting HIV treatment in ERs may be key to ending HIV spread worldwide
In a follow-up study conducted in South Africa, Johns Hopkins Medicine researchers say they have evidence that hospital emergency departments (EDs) worldwide may be key strategic settings for curbing the spread of HIV infections in hard-to-reach populations if the EDs jump-start treatment and case management as well as diagnosis of the disease.

NIH HIV experts prioritize research to achieve sustained ART-free HIV remission
Achieving sustained remission of HIV without life-long antiretroviral therapy (ART) is a top HIV research priority, according to a new commentary in JAMA by experts at the National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health.

The Lancet HIV: PrEP implementation is associated with a rapid decline in new HIV infections
Study from Australia is the first to evaluate a population-level roll-out of pre-exposure prophylaxis (PrEP) in men who have sex with men.

Researchers date 'hibernating' HIV strains, advancing BC's leadership in HIV cure research
Researchers have developed a novel way for dating 'hibernating' HIV strains, in an advancement for HIV cure research.

Read More: HIV News and HIV Current Events is a participant in the Amazon Services LLC Associates Program, an affiliate advertising program designed to provide a means for sites to earn advertising fees by advertising and linking to